PubMed:10224156
Annnotations
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-21 | protein | denotes | Transcription factors |
| T2 | 22-25 | protein | denotes | Sp1 |
| T3 | 30-34 | protein | denotes | AP-2 |
| T4 | 56-77 | protein | denotes | acid sphingomyelinase |
| T5 | 127-161 | cell_line | denotes | human monocytic leukemia cell line |
| T6 | 162-167 | cell_line | denotes | THP-1 |
| T7 | 380-396 | protein | denotes | lysosomal enzyme |
| T8 | 397-418 | protein | denotes | acid sphingomyelinase |
| T9 | 514-525 | cell_line | denotes | THP-1 cells |
| T10 | 556-584 | cell_type | denotes | human mononuclear phagocytes |
| T11 | 611-616 | protein | denotes | RNase |
| T12 | 962-985 | DNA | denotes | 5' deletion derivatives |
| T13 | 993-1019 | DNA | denotes | upstream regulatory region |
| T14 | 1075-1092 | DNA | denotes | promoter elements |
| T15 | 1145-1167 | DNA | denotes | PMA responsive element |
| T16 | 1202-1227 | DNA | denotes | -319 and -219 bp upstream |
| T17 | 1278-1318 | DNA | denotes | transcription factor expression plasmids |
| T18 | 1323-1327 | protein | denotes | AP-2 |
| T19 | 1332-1335 | protein | denotes | Sp1 |
| T20 | 1410-1423 | DNA | denotes | binding sites |
| T21 | 1583-1586 | protein | denotes | Sp1 |
| T22 | 1591-1595 | protein | denotes | AP-2 |
| T23 | 1684-1695 | cell_line | denotes | THP-1 cells |
| T24 | 1790-1807 | cell_line | denotes | PMA-treated cells |
| T25 | 1882-1903 | protein | denotes | transcription factors |
| T26 | 1904-1908 | protein | denotes | AP-2 |
| T27 | 1913-1916 | protein | denotes | Sp1 |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-111 | Sentence | denotes | Transcription factors Sp1 and AP-2 mediate induction of acid sphingomyelinase during monocytic differentiation. |
| S2 | 112-332 | Sentence | denotes | Cells from the human monocytic leukemia cell line THP-1 differentiate towards a macrophage-like phenotype when stimulated with phorbol 12-myristate -13- acetate (PMA), 1,25-dihydroxy-vitamin D3, and various other agents. |
| S3 | 333-585 | Sentence | denotes | We demonstrate here that the expression of the lysosomal enzyme acid sphingomyelinase (ASM; E.C. 3.1.4.12) is induced during this process and is strongly elevated in differentiated THP-1 cells, as well as in differentiated human mononuclear phagocytes. |
| S4 | 586-832 | Sentence | denotes | Using Northern blotting, RNase protection assay, and nuclear run-on analyses, we show that the up-regulation of ASM expression is regulated mainly at the level of transcription and that new protein synthesis is required for enhanced ASM activity. |
| S5 | 833-949 | Sentence | denotes | This cell-type specific induction by PMA treatment was further investigated with respect to transcriptional control. |
| S6 | 950-1142 | Sentence | denotes | A series of 5' deletion derivatives of the upstream regulatory region were used in transient transfection assays to identify promoter elements required for basal and inducible gene expression. |
| S7 | 1143-1459 | Sentence | denotes | A PMA responsive element was localized to a region between -319 and -219 bp upstream of the initiation codon and co-transfections with transcription factor expression plasmids for AP-2 and Sp1 resulted in augmented ASM promoter activity, which was abolished when the binding sites for these two factors were deleted. |
| S8 | 1460-1596 | Sentence | denotes | Using electrophoretic mobility shift assays and supershift assays we demonstrate that this region is specifically bound by Sp1 and AP-2. |
| S9 | 1597-1696 | Sentence | denotes | These factors are present in nuclear extracts prepared from both induced and uninduced THP-1 cells. |
| S10 | 1697-1818 | Sentence | denotes | However, the intensity of the complex formed appeared to increase when nuclear extracts from PMA-treated cells were used. |
| S11 | 1819-2020 | Sentence | denotes | From these studies, we conclude that a concerted action of the transcription factors AP-2 and Sp1 is essential for the up -regulation of ASM expression during the process of macrophage differentiation. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 0-34 | NP | denotes | Transcription factors Sp1 and AP-2 |
| C2 | 698-712 | NP | denotes | ASM expression |
| C4 | 1323-1335 | NP | denotes | AP-2 and Sp1 |
| C5 | 1348-1379 | NP | denotes | augmented ASM promoter activity |
| C6 | 1381-1386 | NP | denotes | which |
| C7 | 1428-1445 | NP | denotes | these two factors |
| C3 | 1185-1458 | NP | denotes | a region between -319 and -219 bp upstream of the initiation codon and co-transfections with transcription factor expression plasmids for AP-2 and Sp1 resulted in augmented ASM promoter activity, which was abolished when the binding sites for these two factors were deleted |
| C8 | 1546-1557 | NP | denotes | this region |
| C9 | 1583-1595 | NP | denotes | Sp1 and AP-2 |
| C10 | 1597-1610 | NP | denotes | These factors |
| C11 | 1878-1916 | NP | denotes | the transcription factors AP-2 and Sp1 |
| C12 | 1956-1970 | NP | denotes | ASM expression |
| R1 | C4 | C1 | coref-ident | AP-2 and Sp1,Transcription factors Sp1 and AP-2 |
| R2 | C6 | C5 | coref-relat | which,augmented ASM promoter activity |
| R3 | C7 | C4 | coref-ident | these two factors,AP-2 and Sp1 |
| R4 | C8 | C3 | coref-ident | this region,"a region between -319 and -219 bp upstream of the initiation codon and co-transfections with transcription factor expression plasmids for AP-2 and Sp1 resulted in augmented ASM promoter activity, which was abolished when the binding sites for these two factors were deleted" |
| R5 | C9 | C7 | coref-ident | Sp1 and AP-2,these two factors |
| R6 | C10 | C9 | coref-ident | These factors,Sp1 and AP-2 |
| R7 | C11 | C10 | coref-ident | the transcription factors AP-2 and Sp1,These factors |
| R8 | C12 | C2 | coref-ident | ASM expression,ASM expression |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-21 | protein_family_or_group | denotes | Transcription factors |
| T2 | 22-25 | protein_molecule | denotes | Sp1 |
| T3 | 30-34 | protein_molecule | denotes | AP-2 |
| T4 | 56-77 | protein_family_or_group | denotes | acid sphingomyelinase |
| T5 | 85-110 | other_name | denotes | monocytic differentiation |
| T6 | 127-161 | cell_line | denotes | human monocytic leukemia cell line |
| T7 | 162-167 | cell_line | denotes | THP-1 |
| T8 | 239-272 | other_organic_compound | denotes | phorbol 12-myristate -13- acetate |
| T9 | 274-277 | other_organic_compound | denotes | PMA |
| T10 | 280-305 | lipid | denotes | 1,25-dihydroxy-vitamin D3 |
| T11 | 380-396 | protein_family_or_group | denotes | lysosomal enzyme |
| T12 | 397-418 | protein_family_or_group | denotes | acid sphingomyelinase |
| T13 | 514-525 | cell_line | denotes | THP-1 cells |
| T14 | 556-584 | cell_type | denotes | human mononuclear phagocytes |
| T15 | 592-609 | other_name | denotes | Northern blotting |
| T16 | 611-616 | protein_molecule | denotes | RNase |
| T17 | 639-662 | other_name | denotes | nuclear run-on analyses |
| T18 | 698-712 | other_name | denotes | ASM expression |
| T19 | 776-793 | other_name | denotes | protein synthesis |
| T20 | 819-831 | other_name | denotes | ASM activity |
| T21 | 870-873 | other_organic_compound | denotes | PMA |
| T22 | 925-948 | other_name | denotes | transcriptional control |
| T23 | 962-985 | DNA_family_or_group | denotes | 5' deletion derivatives |
| T24 | 993-1019 | DNA_domain_or_region | denotes | upstream regulatory region |
| T25 | 1033-1062 | other_name | denotes | transient transfection assays |
| T26 | 1075-1092 | DNA_family_or_group | denotes | promoter elements |
| T27 | 1126-1141 | other_name | denotes | gene expression |
| T28 | 1145-1148 | other_organic_compound | denotes | PMA |
| T29 | 1202-1227 | DNA_domain_or_region | denotes | -319 and -219 bp upstream |
| T30 | 1278-1318 | DNA_family_or_group | denotes | transcription factor expression plasmids |
| T31 | 1323-1327 | protein_molecule | denotes | AP-2 |
| T32 | 1332-1335 | protein_molecule | denotes | Sp1 |
| T33 | 1358-1379 | other_name | denotes | ASM promoter activity |
| T34 | 1410-1423 | DNA_domain_or_region | denotes | binding sites |
| T35 | 1466-1503 | other_name | denotes | electrophoretic mobility shift assays |
| T36 | 1508-1525 | other_name | denotes | supershift assays |
| T37 | 1583-1586 | protein_molecule | denotes | Sp1 |
| T38 | 1591-1595 | protein_molecule | denotes | AP-2 |
| T39 | 1626-1642 | cell_component | denotes | nuclear extracts |
| T40 | 1684-1695 | cell_line | denotes | THP-1 cells |
| T41 | 1768-1784 | cell_component | denotes | nuclear extracts |
| T42 | 1790-1793 | other_organic_compound | denotes | PMA |
| T43 | 1882-1903 | protein_family_or_group | denotes | transcription factors |
| T44 | 1904-1908 | protein_molecule | denotes | AP-2 |
| T45 | 1913-1916 | protein_molecule | denotes | Sp1 |
| T46 | 1938-1952 | other_name | denotes | up -regulation |
| T47 | 1956-1970 | other_name | denotes | ASM expression |
| T48 | 1993-2019 | other_name | denotes | macrophage differentiation |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 143-151 | HP_0001909 | denotes | leukemia |